Companies: 10,795·Total market cap: $144.5T
Genfit S.A.

Genfit S.A.

GNFTFOTCHealthcare● Active
$9.50
+$0.00(+0.00%)
Market Cap$475760219
P/E Ratio
52W High$11.05
52W Low$3.28
Overview

Genfit S.A. (GNFTF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · GNFTF · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-1.69gnftf eps ttm · gnftf earnings per shareEarnings history
PE Ratio (TTM)gnftf pe ratio ttm · gnftf price to earningsPE Ratio deep dive
Revenue (TTM)$134.5Mgnftf revenue ttm · gnftf annual revenueFull revenue history
Dividend YieldNo Dividenddoes gnftf pay dividends · gnftf dividend yieldDividend history
Shares Outstanding49.8Mgnftf shares outstanding · gnftf floatShares outstanding history
Next EarningsSep 29, 2026Est.gnftf earnings date · gnftf next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$65.4M▼ 2.38% YoY
202320242025
genfit s.a. revenue · gnftf revenue 2025
FY 2025Net Income-$85.9M▼ 5802.44% YoY
202320242025
genfit s.a. net income · gnftf profit 2025
FY 2025EPS$-1.73▼ 5866.67% YoY
202320242025
gnftf eps · genfit s.a. earnings per share 2025
TTM:Revenue: $134.5MNet Income: -$84.4MEPS: $-1.69View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy4 analystsis gnftf a buy · gnftf analyst rating
Strong Buy
0
Buy
4
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$9.50Current
$Avg Target
$High
gnftf price target · gnftf 12 month forecast

Total: 4 · Buy rate: 100.0%

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.32%
3M+20.71%
YTD+58.33%
1Y+168.36%
5Y+149.34%

About Genfit S.A.

CEOPascal Prigent
IPO DateJan 27, 2014
Employees180
CountryFR
Websitegenfit.com

Genfit S.A. is a biopharmaceutical company primarily engaged in the discovery and development of innovative therapeutic candidates and diagnostic tools, specifically targeting metabolic and various li…

what is genfit s.a. · gnftf stock overview · genfit s.a. company profile · who is genfit s.a. ceo · gnftf OTC · genfit s.a. headquarters · genfit s.a. business segments

About Stock Overview & Key Data

Genfit S.A. (GNFTF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 27, 2014. As of the latest trading session, GNFTF stock price is $9.50, with a market capitalization of $475.8M. The stock has returned +168.36% over the past 12 months and +58.33% year-to-date.

According to 4 Wall Street analysts, the consensus rating for Genfit S.A. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Genfit S.A. reported revenue of $65.4M and net income of -$85.9M. For detailed data — including Genfit S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Genfit S.A. (GNFTF) stock price is $9.50. The stock is traded on OTC under the ticker symbol GNFTF. The 52-week range is $3.28 – $11.05.

GNFTF stock priceGNFTF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice